Yate-Ching Yuan

16PUBLICATIONS
74CO-AUTHORS
Medical roboticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 23, 2026
TDRD3, a Tudor domain-containing protein, regulates <i>Klf2</i>-dependent T<sub>reg</sub> differentiation and function to modulate immune tolerance.

Yun Shi, Xiaoqun Tao, Lei Shen

|Feb 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma.

Christiane Querfeld, Joycelynne Palmer, Zhen Han

|Feb 13, 2025
Correction: Roy et al. Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy. <i>Cancers</i> 2022, <i>14</i>, 1281.

Souvick Roy, Yinghui Zhao, Yate-Ching Yuan

|Sep 20, 2024
Cancer-associated SF3B1-K700E mutation controls immune responses by regulating T<sub>reg</sub> function via aberrant <i>Anapc13</i> splicing.

Yun Shi, Wencan Zhang, Qiong Jia

|May 24, 2024
1,25-Dihydroxyvitamin D<sub>3</sub> Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line.

Jabril R Johnson, Rachel N Martini, Yate-Ching Yuan

|Apr 13, 2024
Tumor and Peritoneum-Associated Macrophage Gene Signature as a Novel Molecular Biomarker in Gastric Cancer.

Kevin M Sullivan, Haiqing Li, Annie Yang

Pageof 3

Frequent Collaborators

3 joint publications

Zuoming Sun

3 joint publications

Chun-Wei Chen

2 joint publications

Jinhui Wang

2 joint publications

Wencan Zhang